- Senior Investigator, Cancer and Inflammation Program
Dr. Howard Young obtained his Ph.D. in microbiology at the University of Washington and carried out postdoctoral research at the NCI under Drs. Edward Scolnick and Wade Parks. He was a member of the Laboratory of Molecular Immunoregulation at NCI from 1983 to 1989 prior to joining the Laboratory of Experimental Immunology in 1989. He was President of the International Society for Interferon and Cytokine Research (2004-2005) and served as Chair of the Immunology Division of the American Society for Microbiology. He has also served as Chair of the NIH Cytokine Interest Group and Co-Chair of the NIH Immunology Interest Group. He is a two-time recipient of the NIH Director's Award for Mentoring (2000, 2006) and in 2006 he received the National Public Service Award. In 2007 he was named Deputy Chief of the Laboratory of Experimental Immunology.
- (2019). Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 39(10), 586-591.
- (2019). Partners in Crime: Fledgling Tumors Hijack Inflammation. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 39(1), 1-5.
- (2019). Report on the 2018 Cancer, Autoimmunity, and Immunology Conference. JOURNAL OF IMMUNOLOGY. 202(10), 2823-2828.
- (2018). Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions. Cell Reports. 22(6), 1509-1521.